Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Cybex International Q2 Loss Widens

7/24/2012 11:30 AM ET

Cybex International Inc. (CYBI: Quote) Tuesday reported a wider loss for the second quarter, due mainly to lower revenues and weak margins.

The Medway, Massachusetts-based company's second-quarter net loss was $1.21 million or $0.07 per share, compared to $555 thousand or $0.03 per share last year.

Total revenues for the quarter dropped to $30.80 million from $32.56 million in the prior-year quarter.

For the quarter, gross margin decreased to 29.4 percent from 33.8 percent in the year-ago quarter.

Click here to receive FREE breaking news email alerts for Cybex International Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
There was a mixed performance on Wall Street on Friday. Shares suffered an early decline, as investors continued to express worries about the Federal Reserve. A recovery through the rest of the day allowed the Dow to edge into positive territory by the close. The Nasdaq and S&P 500 posted fractional losses. Stocks have shown a notable move to the downside in early trading on Friday amid lingering concerns about the outlook for the Federal Reserve's asset purchase program. The major averages have slid firmly into negative territory, adding to the modest losses posted in the previous session. The major averages are currently posting notable losses, near their lows for the young session. After reporting a sharp drop in new orders for manufactured durable goods in the previous month, the Commerce Department released a report on Friday showing that durable goods orders rebounded by more than anticipated in the month of April. The report said durable goods orders surged up by 3.3 percent in April after tumbling by a revised 5.9 percent in March.
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.